Haematological Malignancies: management of lymphoid and myeloid leukaemia brings together leading experts in the fields of haematology, oncology, transplantation and clinical immunology to discuss the central issues and current challenges facing the management and treatment of patients with leukaemia.

It is anticipated that participants will benefit from:

• Comprehensive overviews of current and novel prognostic markers for each of the leukaemias

• Updates on the current strategies for management and treatment of children and adults with leukaemia

• Insights into promising new treatments for leukaemia, including immunotherapies, antibody treatments and gene therapies

• Understanding of the current issues and latest developments in haematopoietic stem cell transplantation

• An opportunity to share and exchange ideas with leading practitioners in the field